Home » Topics » BioWorld Science

BioWorld Science
RSS

Vasopeptidase inhibitors from Bioprojet to be developed, marketed by Lilly

Oct. 25, 2001

Clinical testing of NIK-333 commences

Oct. 25, 2001

Antiemetic agent developed in Japan to be submitted for approval within the year

Oct. 25, 2001

Micafungin undergoing regulatory review in Japan

Oct. 25, 2001

Phase I/II trial results for CG-7870 discussed at ECCO 11

Oct. 25, 2001

Replagal therapy for Fabry's disease approved in New Zealand and Iceland

Oct. 25, 2001

Trinity Biotech launches new one-step malaria test

Oct. 25, 2001

Phase II trial initiated for BLP25 vaccine for prostate cancer

Oct. 25, 2001

Inhibitors of proinflammatory proteins under study at GSK

Oct. 24, 2001

Condensed thiazolamines from Novartis act as antagonists at the Y5 receptor

Oct. 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...